GlobeNewswire

CCP Now Lansdale Brings Specialized Walk-In Cardiac Care to Montgomery County
12/11/2026
LANSDALE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cardiology Consultants of Philadelphia (CCP), the region’s leading cardiology practice, today announced that CCP Now Lansdale is open and actively serving patients at [...]
Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026
12/11/2026
Among patients previously on long-term prophylaxis (LTP) in HAELO Phase 3 trial, monthly attack rate decreased by 81% following lonvo-z dosing compared with prior LTP 100% of patients receiving 50 mg of lonvo-z across [...]
ALK to present positive phase II data on its tablet for the treatment of peanut allergy at ACAAI 2026
12/11/2026
ALK will present phase II data from the ALLIANCE trial of its once-daily investigational sublingual immunotherapy (SLIT) tablet for peanut allergy 1,2,3 at the American College of Allergy, Asthma & Immunology (ACAAI [...]
NYC Mommy Makeover Center Supports Local Moms as Mommy Makeover Interest Jumps 60%
12/11/2026
As New York moms explore post-pregnancy surgery, the NYC Mommy Makeover Center offers guidance on procedures, timing and recovery NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- More New York moms are looking into mommy [...]
NeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial
12/11/2026
Recent purchases total 150,000 shares as NeOnc prepares to discuss potential accelerated approval and a Phase 3 confirmatory trial for NEO100 DALLAS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ( www.InvestorsTape.com )— NeOnc [...]
Pharvaris Presents Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting
12/11/2026
Phase 3 CHAPTER-3 results to be presented in the Distinguished Industry and Late-breaking Oral Abstracts sessions on Saturday, November 14, from 4:30-6:00 p.m. MST CHAPTER-3 met the primary and all secondary efficacy [...]
Patients Know Best Launches in Australia through Consultmed partnership
12/11/2026
Cambridge, UK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Patients Know Best (PKB) has partnered with Consultmed , an Australian digital referral and workflow platform used by health services across multiple Australian states, [...]
Ally Medical ER Named a 2026 Top Workplace by Houston Chronicle, Earns Best Manager Award
12/11/2026
Employee feedback earns the freestanding emergency room top honors as its Houston-area team continues to grow HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- The Houston Chronicle has named Ally Medical Emergency Room (Ally [...]
Lungpacer Medical Announces First Patient Enrollment in AERO-PAS Post-Approval Study of the AeroPace® System
12/11/2026
Sutter Health's California Pacific Medical Center in San Francisco opens the multicenter study, which will evaluate the continued real-world safety and effectiveness of transvenous diaphragm neurostimulation to [...]
QUAD A Announces Dr. Monte Jay Goldstein as President of Its Board of Directors
12/11/2026
Experienced anesthesiologist and ambulatory surgery executive brings decades of clinical, operational, and accreditation expertise to the role. HIGHLAND PARK, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- QUAD A, The Global [...]
New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)
12/11/2026
RemIND data show clinically meaningful responses through Week 52 across three most prevalent CIndU subtypes, including after switching from placebo at Week 24 1 Twice as many Rhapsido-treated patients achieved a [...]
Ennature Biopharma Advances Curcumin Formulation With Water-Dispersible Maxicuma
12/11/2026
NOIDA, India, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Curcumin , a compound in turmeric ( Curcuma longa ), has long presented a challenge for supplement manufacturers: Its poor water dispersibility and limited absorption make [...]
Ally Medical ER Wins Midsize Company Category for Fourth Straight Year in Austin American-Statesman Top Workplaces
12/11/2026
The freestanding emergency room also earned the Doer Award as it continues to grow across the greater Austin area AUSTIN, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room (Ally Medical ER), which [...]
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis and FDA feedback on BLA submission pathway in 1H 2027 TSHA-102 continues to be [...]
Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale
12/11/2026
Le Fonds de recherche en santé buccodentaire de la famille Leger soutiendra des travaux visant à mieux comprendre les liens entre la santé buccodentaire, la santé globale et les maladies chroniques TORONTO, 12 nov. 2026 [...]
123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health
12/11/2026
The Leger Family Oral Health Research Fund will back research that deepens understanding of how oral health connects to overall health and chronic disease TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Jeff Leger, Chief [...]
Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials
12/11/2026
BD200 is a multibody drug conjugate, in which each arm of the antibody can alternatively bind to either Nectin-4 or Trop2, two validated oncology antigens that may be expressed on cancer cells Combined with a unique [...]
Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2026
WAYNE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
12/11/2026
PCAOB audited FY2024 and FY2025 and reviewed unaudited six months ended June 30, 2026 financials of G3 and its consolidated subsidiaries (“G3”) delivered In FY 2025, the Combined G3 company had consolidated revenue of $ [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum